Abstract

Notwithstanding its acknowledged pivotal role for cardiovascular prevention, cardiac rehabilitation (CR) is still largely under prescribed, in almost 25% of patients owing an indication for. In addition, when considering differences concerning the two sexes, female individuals are underrepresented in CR programmes with lower referral rates, participation, and completion as compared to male counterpart. This picture becomes even more tangled with reference to gender, a complex socio-cultural construct characterized by four domains (gender identity, relation, role, and institutionalized gender). Indeed, each of them reveals several obstacles that considerably penalize CR adherence for different categories of people, especially those who are not identifiable with a non-binary gender. Aim of the present review is to identify the sex- (i.e. biological) and gender- (i.e. socio-cultural) specific obstacles to CR related to biological sex and sociocultural gender and then envision a likely viable solution through tailored treatments towards patients’ well-being.

Introduction

Cardiac rehabilitation (CR) is defined as an interdisciplinary comprehensive programme based on physical training, with a concomitant complementary counselling made by trained physiotherapists, changes in modifiable cardiovascular (CV) risk factors, psychosocial support, and patient education about nutritional assessment.1,2 CR represents a pivotal tool in improving exercise capacity, quality of life, and clinical outcomes in different CV diseases (CVD), through different mechanisms (Figure 1). Following evidence from epidemiology and clinical studies, the most recent European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend CR in patients with several CVD, enlisted in Table 1; in brief, CR is recommended by guidelines in coronary artery disease in order to reduce CV mortality and rehospitalisations,3–5 in patients affected by acute myocardial infarction (MI), coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), pulmonary arterial hypertension,6,7 and in chronic heart failure (HF) to improve exercise capacity and quality of life and reduce HF hospitalisation.8,9 In addition, despite the lack of a specific guideline-based recommendation, a recent position paper made by Ambrosetti et al.10 suggests CR also for valve surgery, both for minimally invasive cardiothoracic surgery and aortic valve replacement, to improve short-term physical activity.

Wide beneficial effects of exercise training and cardiac rehabilitation in patients with heart failure.
Figure 1

Wide beneficial effects of exercise training and cardiac rehabilitation in patients with heart failure.

Table 1

European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) recommendations for cardiac rehabilitation in cardiovascular diseases

ESC guidelinesACC/AHA guidelinesNotes
Heart failureIA (2021)IA (2022)
Acute coronary syndromes
 Persistent ST-segment elevationIA (2023)IB*(2014)*Either Before Hospital discharge or during first outpatient visit
 Unstable anginaIA (2023)IB* (2014)°Exercise-based cardiac rehabilitation/secondary prevention programmes are recommended for patients with STEMI (Level of Evidence: B)
 Patients with ST-segment elevationIA (2023)IB° (2013)
Chronic coronary syndromesIA (2019)I§ (2023)§All patients with chronic coronary disease and appropriate indications should be referred to a cardiac rehabilitation programme to improve outcomes. Level of evidence (LOE) A: After recent MI, percutaneous coronary intervention, or CABG; LOE B-R: With stable angina or after heart transplant; LOE C-LD: after recent spontaneous coronary artery dissection event
Myocardial revascularization:
 Coronary artery bypass graft surgery (CABG)IA (2018)IA§ (2021)§Either before hospital discharge or during first outpatient visit
 Percutaneous coronary interventionIA (2018)IA§ (2021)
Aortic diseaseIC£ (2022)£For patients who have undergone surgery for aortic aneurysm or dissection, post-operative cardiac rehabilitation is recommended
Peripheral arterial diseaseIA (2017)^IA (2016)^For supervised exercise training in patients with intermittent claudication. I C for unsupervised exercise training when supervised exercise training is not feasible or available. IIa C when daily life activities are compromised despite exercise therapy, revascularization should be considered. IIa B when daily life activities are severely compromised, revascularization should be considered in association with exercise therapy
Pulmonary hypertensionIA (2022)″″Supervised exercise training is recommended in class IA for patients with PAH under medical therapy
ESC guidelinesACC/AHA guidelinesNotes
Heart failureIA (2021)IA (2022)
Acute coronary syndromes
 Persistent ST-segment elevationIA (2023)IB*(2014)*Either Before Hospital discharge or during first outpatient visit
 Unstable anginaIA (2023)IB* (2014)°Exercise-based cardiac rehabilitation/secondary prevention programmes are recommended for patients with STEMI (Level of Evidence: B)
 Patients with ST-segment elevationIA (2023)IB° (2013)
Chronic coronary syndromesIA (2019)I§ (2023)§All patients with chronic coronary disease and appropriate indications should be referred to a cardiac rehabilitation programme to improve outcomes. Level of evidence (LOE) A: After recent MI, percutaneous coronary intervention, or CABG; LOE B-R: With stable angina or after heart transplant; LOE C-LD: after recent spontaneous coronary artery dissection event
Myocardial revascularization:
 Coronary artery bypass graft surgery (CABG)IA (2018)IA§ (2021)§Either before hospital discharge or during first outpatient visit
 Percutaneous coronary interventionIA (2018)IA§ (2021)
Aortic diseaseIC£ (2022)£For patients who have undergone surgery for aortic aneurysm or dissection, post-operative cardiac rehabilitation is recommended
Peripheral arterial diseaseIA (2017)^IA (2016)^For supervised exercise training in patients with intermittent claudication. I C for unsupervised exercise training when supervised exercise training is not feasible or available. IIa C when daily life activities are compromised despite exercise therapy, revascularization should be considered. IIa B when daily life activities are severely compromised, revascularization should be considered in association with exercise therapy
Pulmonary hypertensionIA (2022)″″Supervised exercise training is recommended in class IA for patients with PAH under medical therapy
Table 1

European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) recommendations for cardiac rehabilitation in cardiovascular diseases

ESC guidelinesACC/AHA guidelinesNotes
Heart failureIA (2021)IA (2022)
Acute coronary syndromes
 Persistent ST-segment elevationIA (2023)IB*(2014)*Either Before Hospital discharge or during first outpatient visit
 Unstable anginaIA (2023)IB* (2014)°Exercise-based cardiac rehabilitation/secondary prevention programmes are recommended for patients with STEMI (Level of Evidence: B)
 Patients with ST-segment elevationIA (2023)IB° (2013)
Chronic coronary syndromesIA (2019)I§ (2023)§All patients with chronic coronary disease and appropriate indications should be referred to a cardiac rehabilitation programme to improve outcomes. Level of evidence (LOE) A: After recent MI, percutaneous coronary intervention, or CABG; LOE B-R: With stable angina or after heart transplant; LOE C-LD: after recent spontaneous coronary artery dissection event
Myocardial revascularization:
 Coronary artery bypass graft surgery (CABG)IA (2018)IA§ (2021)§Either before hospital discharge or during first outpatient visit
 Percutaneous coronary interventionIA (2018)IA§ (2021)
Aortic diseaseIC£ (2022)£For patients who have undergone surgery for aortic aneurysm or dissection, post-operative cardiac rehabilitation is recommended
Peripheral arterial diseaseIA (2017)^IA (2016)^For supervised exercise training in patients with intermittent claudication. I C for unsupervised exercise training when supervised exercise training is not feasible or available. IIa C when daily life activities are compromised despite exercise therapy, revascularization should be considered. IIa B when daily life activities are severely compromised, revascularization should be considered in association with exercise therapy
Pulmonary hypertensionIA (2022)″″Supervised exercise training is recommended in class IA for patients with PAH under medical therapy
ESC guidelinesACC/AHA guidelinesNotes
Heart failureIA (2021)IA (2022)
Acute coronary syndromes
 Persistent ST-segment elevationIA (2023)IB*(2014)*Either Before Hospital discharge or during first outpatient visit
 Unstable anginaIA (2023)IB* (2014)°Exercise-based cardiac rehabilitation/secondary prevention programmes are recommended for patients with STEMI (Level of Evidence: B)
 Patients with ST-segment elevationIA (2023)IB° (2013)
Chronic coronary syndromesIA (2019)I§ (2023)§All patients with chronic coronary disease and appropriate indications should be referred to a cardiac rehabilitation programme to improve outcomes. Level of evidence (LOE) A: After recent MI, percutaneous coronary intervention, or CABG; LOE B-R: With stable angina or after heart transplant; LOE C-LD: after recent spontaneous coronary artery dissection event
Myocardial revascularization:
 Coronary artery bypass graft surgery (CABG)IA (2018)IA§ (2021)§Either before hospital discharge or during first outpatient visit
 Percutaneous coronary interventionIA (2018)IA§ (2021)
Aortic diseaseIC£ (2022)£For patients who have undergone surgery for aortic aneurysm or dissection, post-operative cardiac rehabilitation is recommended
Peripheral arterial diseaseIA (2017)^IA (2016)^For supervised exercise training in patients with intermittent claudication. I C for unsupervised exercise training when supervised exercise training is not feasible or available. IIa C when daily life activities are compromised despite exercise therapy, revascularization should be considered. IIa B when daily life activities are severely compromised, revascularization should be considered in association with exercise therapy
Pulmonary hypertensionIA (2022)″″Supervised exercise training is recommended in class IA for patients with PAH under medical therapy

Nevertheless, CR is still globally largely under prescribed. For instance, among 366 103 eligible Medicare beneficiaries in 2016, it has been reported that only 89 327 (∼24%) attended CR, of which ∼57% completed more than 24 CR sessions and around 27% completed 36 CR sessions, implicating missed opportunities to potentially improve health outcomes.11

As reported in the most recent position paper of the Italian Association for Cardiovascular Prevention and Rehabilitation (formerly GICR-IACPR),12 based on the findings of a multi-centre survey,13 the total offer remains still very low, involving no more than 30–35% of the potential patients despite an increase in a 5-year period of around 20% of the number of facilities addressing CR.

In this context, the lack of accessibility to CR programme with clear sex-based disparities is a matter of immediate concern14; women are less likely to be enrolled and complete CR compared with men.11,15,16 In addition, the lower attendance of women to CR programme has been reported to be dependent on a gendered cluster of vulnerability which include specific socio-economic, psychological, and cultural patterns. Indeed, gender is a complex socio-cultural construct characterized by four domains (gender identity, relation, role, and institutionalized gender). Beyond biological sex, sociocultural gender represents a major driver of the disparities in the access to CR programme.17

Therefore, the aim of the present review is to shed light upon sex and gender differences in CR, their underlying causes, their effects on clinical outcomes, and the possible strategies to improve this trend.

Cardiovascular rehabilitation programmes: why sex and gender matter

In recent years, there has been an increasing awareness on how ‘sex’ and ‘gender’ capture different aspects of people and constantly intersect to shape health and diseases.18 While sex identifies the biological attributes (that are dependent on chromosomes, genes, reproductive, and endocrine systems), ‘gender’ is a multi-dimensional concept that comes from social science that can be broken down in four main domains: (i) gender identity, that is the personal perception of one's own gender (which might be different from the sex a person is assigned at birth), (ii) gender roles, which include behaviours and attitudes considered appropriate by the society on basis of the sex, (iii) gender relations, that consist on how one interacts with others and how is treated according to the sex and gender, and (iv) institutionalized gender, that mirrors the structural distribution of power between genders in the political, educational, religious, medical, cultural, and social institutions of a society18,19—see Figure 2. Sex and gender might be difficult to tease apart and frequently they are interconnected. The main goal of sex and gender informed medicine is to deliver fair and equitable, patient-specific treatments to improve and strengthen both therapy and patients’ prognosis. In the CV clinical setting, the awareness on the impact of sex and gender as modifiers of patient outcomes has increased overtime and recently guidelines have been provided on how to integrate sex and gender in CV research.20 Furthermore, reporting of SOGIE (sexual orientation and gender identity and expression) data have been strongly recommended to guarantee equity, inclusion, and diversity in evidence that guide CV clinical work.21

Description of the four domains that characterize the definition of gender.
Figure 2

Description of the four domains that characterize the definition of gender.

In the context of CR, it has been demonstrated that there are remarkable sex disparities in CR referral, participation, and completion.22

Generally speaking, there is a lack of facilities dedicated to CR represented by only one spot for every seven patients in need, with a great need for developing countries.23 To date, it is not understood how much gender, broadly viewed as a set of the four constituent domains, influences reduced therapeutic adherence to CR. Therefore, in the absence of evidence, it is appropriate to parcel out its domains to postulate its importance. The difference in CR referral and participation among sexes is consistent with several evidence showing key distinction in clinical presentation, diagnosis, treatment, and clinical outcomes of CV patients.22 In a recent review Arcopinto et al.19 highlighted the involvement of sex-specific factors, such as role of oestrogens and pregnancy-related cardiomyopathies, in the incidence of different HF patterns, with women affected more frequently by HF with preserved ejection fraction and higher number of comorbidities. Instead, male individuals showed a predisposition of developing HF with reduced ejection fraction (HFrEF), due to a higher incidence of coronary artery disease and MI. In this regard, the large under-representation of women in clinical trials leads to an incomplete characterisation, and thus knowledge, of a large group of patients. This clinical scenario is further tangled by the presence of gendered socioeconomic and cultural differences between men and women that transcend the mere biological sex.

Specifically, lower rates of women in comparison with men (18.9% vs. 28.6%) have been reported in CR participation, with a decrease as age increases.11 Due to the greater burden of CV risk factors and the higher mortality rate,24 it has been suggested that theoretically women would benefit the most from secondary prevention through CR; yet, they are still less likely to receive a proper CR referral, with a significant impact on their health status. With this regard, among 48 993 patients of the American Heart Association Get with The Guidelines Coronary Artery Disease registry, Li et al.15 found that women were 12% less likely to be referred to CR than men, even though the CR referral was associated with a reduction of 40% in 3-years all-cause mortality, and women with a CR referral at hospital discharge showed a lower mortality when compared with those who did not. It is not known whether the reduced participation in CR depended on a lack of physician referral or whether, after the CR prescription, patients decided not to participate. Despite a slight increase in CR referral rate overtime, this positive trend involved men more than women as depicted in a study among Medicare beneficiaries with HFrEF from the 2014 to 2016.16 In fact, among 11 696 hospitalized HF patients, only 4.3% participated in CR within 6 months of HF hospitalisation, with lower participation in women vs. men (3.3% vs. 5%; P < 0.001). The same picture was obtained for outpatients with HF: among 11 832 patients with outpatient encounters for primary HF diagnosis without a hospitalization event, only 2.2% participated in CR within 6 months of the outpatient encounter.16 Samayoa et al.25 showed that <40% of women with acute coronary syndrome (i.e. MI or unstable angina), chronic stable angina, stable chronic HF, or undergoing PCI, CABG surgery, cardiac valve surgery, cardiac transplantation, or cardiac resynchronization therapy eligible for CR were enrolled, highlighting a 36% lower enrolment rate in women compared with men. In a meta-analysis, Colella et al.26 showed that CR referral rates for women were 39.6% on average compared to 49.4% for men. Colbert et al.27 in a recent study demonstrated that, in a cohort of 25 958 patients with coronary artery disease, 6374 were women and there was a lower rate for females than males of CR referral (31.1% vs. 42.2%) and completion (50.1% vs. 60.4%). The survival was greater among patients who attended CR compared to those who were referred but did not participate; moreover, women not referred to CR exhibited the highest mortality of all subjects and a higher mortality when compared with men not referred.27 In fact, women referred to CR, even if they did not attend, showed a significantly improved survival when compared to those not referred and even more whether they completed the programme; likewise, men exhibited survival benefits derived from referral and even more so from participation in CR. However, the relative survival benefit derived from the completion of CR was larger in women than in men.27 Therefore, the benefits from CR are known among women, but difficulties related to transportation and family responsibilities often may affect their participation in CR programme. A recent retrospective study from the United States on patients enrolled in intensive-cardiac-rehabilitation (ICR) from January 2016 to December 2020 stressed the importance of not exercise-related components of CR in order to reduce the barriers in participation and the gap between sexes.28 Among 15 613 patients the rates of participation in ICR were about 44% for women (n = 6788) and 56% for men (n = 8825), demonstrating a lower women-disparity than in previous studies.28 Furthermore, the difference in ICR completion was lessened with an exhibited rate of 63.3% for women and 65.9% for men.28 The adherence to CR shows sex differences: men and women enrolled in CR adhered to 68.6% and 64.2% of prescribed sessions, respectively29 (Table 2).

Table 2

Main studies highlighting the under-representation of women in cardiovascular rehabilitation programmes

StudyMain results
Ritchey MD, 2020.11 Observational study. 366.103 CR-eligible beneficiaries89 327 (24.4%) participated in CR, of whom 24.3% initiated within 21 days of event and 26.9% completed CR. Participation: women (18.9%) vs. men (28.6%)
Samayoa L, 2014.25 Systematic review and meta-analysis of 26 eligible observational studies. 297 719 participants (128 499 [43.2%] women)45.0% of men and 38.5% of women enrolled in CR. Women 36% less likely to be enrolled in a rehabilitation programme
Colella TJ, 2015.26 Meta-analysis of 19 observational studies. 241 613 participants (80 505 [33.3%] women)In the pooled analysis (39.6%) significantly less likely to be referred to CR compared to men (49.4%)
Colbert JD, 2015.27 Retrospective cohort study. 25 958 subjects (6374 [24.6%] women) with at least one vessel CAD.Among females reduced rates of CR referral (31.1% vs. 42.2%) and completion (50.1% vs. 60.4%). Women completing CR experienced the greatest reduction in mortality with a relative benefit greater than men.
Hussain Jafri SH, 2023.28 Retrospective cohort study. 15 613 patients (6788 [44%] women) enrolled in 46 Ornish-intensive cardiac rehabilitation (ICR) programmesICR completion rates were 64.7% overall and nearly equal between men and women (63.3% women vs. 65.9% men)
Oosenbrug E, 2016.29 Meta-analysis including 14 studies. 8176 participants (2234 [27.3%] women).Cr adherence ranged from 36.7% to 84.6% of sessions, with a mean 66.5 ± 18.2% (median, 72.5%). Men and women enrolled in CR adhered to 68.6% and 64.2% prescribed sessions, respectively.
Ghisi GLM, 2023.30 Cross-sectional study. 2163 patients (916 [42.8%] women) from 16 countries across all 6 WHO regions.1239/57.8%) patients referred to CR. Differences in referral rate to CR according to sex: 368 women (40.4% of the female group) vs. 866 men (71.0% of the male group). 571 (27.8%) patients participated in CR. Differences in participation rate in CR according to sex: 284 women (34.1% of the female group) vs. 283 men (23.5% of the male group).
StudyMain results
Ritchey MD, 2020.11 Observational study. 366.103 CR-eligible beneficiaries89 327 (24.4%) participated in CR, of whom 24.3% initiated within 21 days of event and 26.9% completed CR. Participation: women (18.9%) vs. men (28.6%)
Samayoa L, 2014.25 Systematic review and meta-analysis of 26 eligible observational studies. 297 719 participants (128 499 [43.2%] women)45.0% of men and 38.5% of women enrolled in CR. Women 36% less likely to be enrolled in a rehabilitation programme
Colella TJ, 2015.26 Meta-analysis of 19 observational studies. 241 613 participants (80 505 [33.3%] women)In the pooled analysis (39.6%) significantly less likely to be referred to CR compared to men (49.4%)
Colbert JD, 2015.27 Retrospective cohort study. 25 958 subjects (6374 [24.6%] women) with at least one vessel CAD.Among females reduced rates of CR referral (31.1% vs. 42.2%) and completion (50.1% vs. 60.4%). Women completing CR experienced the greatest reduction in mortality with a relative benefit greater than men.
Hussain Jafri SH, 2023.28 Retrospective cohort study. 15 613 patients (6788 [44%] women) enrolled in 46 Ornish-intensive cardiac rehabilitation (ICR) programmesICR completion rates were 64.7% overall and nearly equal between men and women (63.3% women vs. 65.9% men)
Oosenbrug E, 2016.29 Meta-analysis including 14 studies. 8176 participants (2234 [27.3%] women).Cr adherence ranged from 36.7% to 84.6% of sessions, with a mean 66.5 ± 18.2% (median, 72.5%). Men and women enrolled in CR adhered to 68.6% and 64.2% prescribed sessions, respectively.
Ghisi GLM, 2023.30 Cross-sectional study. 2163 patients (916 [42.8%] women) from 16 countries across all 6 WHO regions.1239/57.8%) patients referred to CR. Differences in referral rate to CR according to sex: 368 women (40.4% of the female group) vs. 866 men (71.0% of the male group). 571 (27.8%) patients participated in CR. Differences in participation rate in CR according to sex: 284 women (34.1% of the female group) vs. 283 men (23.5% of the male group).
Table 2

Main studies highlighting the under-representation of women in cardiovascular rehabilitation programmes

StudyMain results
Ritchey MD, 2020.11 Observational study. 366.103 CR-eligible beneficiaries89 327 (24.4%) participated in CR, of whom 24.3% initiated within 21 days of event and 26.9% completed CR. Participation: women (18.9%) vs. men (28.6%)
Samayoa L, 2014.25 Systematic review and meta-analysis of 26 eligible observational studies. 297 719 participants (128 499 [43.2%] women)45.0% of men and 38.5% of women enrolled in CR. Women 36% less likely to be enrolled in a rehabilitation programme
Colella TJ, 2015.26 Meta-analysis of 19 observational studies. 241 613 participants (80 505 [33.3%] women)In the pooled analysis (39.6%) significantly less likely to be referred to CR compared to men (49.4%)
Colbert JD, 2015.27 Retrospective cohort study. 25 958 subjects (6374 [24.6%] women) with at least one vessel CAD.Among females reduced rates of CR referral (31.1% vs. 42.2%) and completion (50.1% vs. 60.4%). Women completing CR experienced the greatest reduction in mortality with a relative benefit greater than men.
Hussain Jafri SH, 2023.28 Retrospective cohort study. 15 613 patients (6788 [44%] women) enrolled in 46 Ornish-intensive cardiac rehabilitation (ICR) programmesICR completion rates were 64.7% overall and nearly equal between men and women (63.3% women vs. 65.9% men)
Oosenbrug E, 2016.29 Meta-analysis including 14 studies. 8176 participants (2234 [27.3%] women).Cr adherence ranged from 36.7% to 84.6% of sessions, with a mean 66.5 ± 18.2% (median, 72.5%). Men and women enrolled in CR adhered to 68.6% and 64.2% prescribed sessions, respectively.
Ghisi GLM, 2023.30 Cross-sectional study. 2163 patients (916 [42.8%] women) from 16 countries across all 6 WHO regions.1239/57.8%) patients referred to CR. Differences in referral rate to CR according to sex: 368 women (40.4% of the female group) vs. 866 men (71.0% of the male group). 571 (27.8%) patients participated in CR. Differences in participation rate in CR according to sex: 284 women (34.1% of the female group) vs. 283 men (23.5% of the male group).
StudyMain results
Ritchey MD, 2020.11 Observational study. 366.103 CR-eligible beneficiaries89 327 (24.4%) participated in CR, of whom 24.3% initiated within 21 days of event and 26.9% completed CR. Participation: women (18.9%) vs. men (28.6%)
Samayoa L, 2014.25 Systematic review and meta-analysis of 26 eligible observational studies. 297 719 participants (128 499 [43.2%] women)45.0% of men and 38.5% of women enrolled in CR. Women 36% less likely to be enrolled in a rehabilitation programme
Colella TJ, 2015.26 Meta-analysis of 19 observational studies. 241 613 participants (80 505 [33.3%] women)In the pooled analysis (39.6%) significantly less likely to be referred to CR compared to men (49.4%)
Colbert JD, 2015.27 Retrospective cohort study. 25 958 subjects (6374 [24.6%] women) with at least one vessel CAD.Among females reduced rates of CR referral (31.1% vs. 42.2%) and completion (50.1% vs. 60.4%). Women completing CR experienced the greatest reduction in mortality with a relative benefit greater than men.
Hussain Jafri SH, 2023.28 Retrospective cohort study. 15 613 patients (6788 [44%] women) enrolled in 46 Ornish-intensive cardiac rehabilitation (ICR) programmesICR completion rates were 64.7% overall and nearly equal between men and women (63.3% women vs. 65.9% men)
Oosenbrug E, 2016.29 Meta-analysis including 14 studies. 8176 participants (2234 [27.3%] women).Cr adherence ranged from 36.7% to 84.6% of sessions, with a mean 66.5 ± 18.2% (median, 72.5%). Men and women enrolled in CR adhered to 68.6% and 64.2% prescribed sessions, respectively.
Ghisi GLM, 2023.30 Cross-sectional study. 2163 patients (916 [42.8%] women) from 16 countries across all 6 WHO regions.1239/57.8%) patients referred to CR. Differences in referral rate to CR according to sex: 368 women (40.4% of the female group) vs. 866 men (71.0% of the male group). 571 (27.8%) patients participated in CR. Differences in participation rate in CR according to sex: 284 women (34.1% of the female group) vs. 283 men (23.5% of the male group).

Gender issues in cardiac rehabilitation

The drivers of the abovementioned sex disparities in CR utilization might be influenced by the socio-economic, psychological, and cultural differences, which are part of the ‘gender’ concept.31,32 Specifically, barriers for accessing CR have been reported to be strongly dependent by both individual and structural levels.2 Although there are still no specific studies directed towards understanding the impact of various gender domains on CR, the application of a gender-based framework to understand obstacles and challenges of CR among patients eligible for it can be very informative.

Gender identity and sexual orientation

Among the concept of gender identity, a vast spectrum of self-perception exists (girls, women, boys, men, and gender diverse people). With the term ‘transgender’ it is defined a person who does not identify with the sex assigned at the birth in contrast to ‘cisgender’, in which sex and gender match. According to the minority stress theory, the transgenders represent a minority of population characterized by disparities in the access to healthcare system, due to social barriers, namely gender non-affirmation (e.g. being called by incorrect pronoun or name), stigma, discrimination, rejection, hypervigilance, concealment, and victimization that influence negatively their mental and physical health.33 In the report of the 2015 U.S. transgender survey34 came to light numerous difficulties for transgender people in terms of adequate access to health care due to economic up to social aspects. In fact, the insurance coverage was often denied due to being transgender or because of care related to gender transition. A higher rate of poverty and unemployment was frequent among this population and one-third of them showed in the previous year at least a negative experience related to the gender identity in terms of verbal harassment or treatment refused. 23% of them rejected to see a doctor due to the fear of mistreatment for being transgender. Moreover, a great number of transgender people wanted counselling at certain point of the life, and discrimination and marginalization contribute to the psychological distress that could result in a high rate of suicide attempts. Alzahrani et al.35 depicted that men who are transgender had a significant higher prevalence of MI compared to cisgender women and cisgender men; conversely women who are transgender showed a significant higher prevalence of MI compared with cisgender women but not when compared with cisgender men.35 In a recent review Connelly et al.36 collected some retrospective studies carried on adult transgenders to investigate the CV effects of hormonal therapy. The authors underlined that, in contrast with current evidence, there were discrepant results regarding the relationship between the use of oestrogens by transgender females (TGFs) that are individuals assigned to male sex who identify themselves as female, and an increased risk of MI and ischaemic stroke. Furthermore, studies on transgenders are limited and contradictory and often it remains unclear if CV morbidity and mortality are only ascribable to the hormonal therapy or if there is a component related to the natal sex. In addition, the results are subordinated to the rate of traditional CV risk factors, unhealthy behaviours and additional risk factors (i.e. HIV infection) in this population.

Gender roles

For female caregivers, familial and household responsibilities represent an influential obstacle to CR.31 More frequently women put forward familial responsibilities as obstacles for CR, having difficulties to make time for their prevention. Moreover, sometimes, women consider exercise training as an inappropriate behaviour for a lady.37,38 Additionally, because of logistic problems such as dependence on others for transportation and, differently from men, less encouragement from the spouse, women’s attendance at CR decreases.37 To this extent, it would be appropriate for health care authorities to be made aware and alerted to these disparities so that appropriate corrective measures may be placed.

Gender relations

In a meta-analysis, it has been demonstrated that being married/partnered is associated with a significant higher attendance at CR in patients with coronary heart disease.39 Among these patients, those married or with a partner were 1.5–2 times more likely to attend at outpatient CR. Among patients referred to CR after acute MI the baseline characteristics of non-participants compared with participants were more likely to be elderly, female, and with more CV risk factors and comorbidities.40–42 One hypothetical intervention that could be implemented would be to provide psychotherapeutic-relational support, especially for those individuals whose CV risk is remarkably high.

Institutionalized gender

Unemployed and less educated people and those with lower income had a lower participation.41 In the literature, there are several qualitative studies on women’s barriers to CR and on sex differences in relation to these obstacles, but only few quantitative studies. Three quantitative studies on sex differences in CR barriers used a validated scale, the cardiac rehabilitation barrier scale (CRBS).43 One of them, carried on patients of a high-income and very gender-equal Canadian country, showed no sex differences in total number of CR barriers, but a diverse nature of barriers according to sex.44 Conversely, another study, conducted on patients of middle-income and gender-unequal Iranian country, exhibited significantly greater overall barriers among women and in addition to the sex differences of the former study showed some differences related to the socioeconomic status (i.e. cost, transportation, and distance).45 Ghisi et al.30 in a landmark cross-sectional study carried on 2163 patients, of which 916 were women (42.8%), from 16 countries across six WHO regions from October 2021 to March 2023, had shown that women’s barriers to CR were greatest in the Western Pacific and South East Asian regions and, in both cases, had individuated the lack of CR awareness as major responsible. The CRBS was used to assess the barriers perceived by patients to CR enrolment and adherence.30 Furthermore, women’s unemployment increased barriers to CR. On one hand, among non-enrolled referred women, obstacles were lack of awareness of CR, absence of contact by the programme, cost, and the belief that exercise would be tiring or painful. On the other hand, enrolled women identified as greatest barriers to adherence the distance, transportation, and family responsibilities.30

Summarizing, some of the most frequent issues reported by patients in relation to reduced CR attendance are anxiety to exercise, overburden due to medical appointments, barriers in the interaction with CR staff, lack of awareness or skepticism about the resulting benefits, logistical problems due to distance from the hospital, costs, transportation/parking, employment, and social and familial responsibilities31,46 (Figure 3). The lack of CR referral and the hesitation of women due to emotional, relational, economic, cultural, and logistical barriers contribute to a lower level of participation or adherence to CR.46,47 Several studies had examined the principal barriers that women mentioned for non-attendance at CR. Some of these are related to personal issues (e.g. insufficient time, lack of motivation, religious conflicts, economic, and logistical difficulties), whereas others are associated with interpersonal aspects, linked to inadequacy in social and familial support—which correlates with the domain of gender relations and employment—correlated with the domain of institutionalized gender.48 In a secondary meta-synthesis, Angus et al.37 observed that gender issues and socioeconomic status are involved in sex disparities when accessing rehabilitation. More precisely, on the one hand difficulties related to employment duties and transportation, especially if there is a lack of financial resources, are more frequently mentioned by men as a cause of non-attendance. On the other hand, women advocate more frequently domestic, familial, and economic responsibilities; in addition, even in the case of no enrolment fees, women have to make time for their prevention, paying for a housekeeper or family caregiver.37 In a recent systematic review, Galati et al.49 underlined that women who do not complete the CR programme were significantly younger, affected by more risk factors, and with greater rate of anxiety and depression in comparison with women who complete CR. Lastly, physicians play a crucial role in addressing candidate patients to rehabilitation, yet often they are perceived as barriers to referral.50

Some of the gender issues on the attendance at cardiac rehabilitation. Access to CR can become cumbersome in the presence of several superposed gender-related issues which result in a burden too great to be carried, ultimately leading to drop out of this secondary prevention.
Figure 3

Some of the gender issues on the attendance at cardiac rehabilitation. Access to CR can become cumbersome in the presence of several superposed gender-related issues which result in a burden too great to be carried, ultimately leading to drop out of this secondary prevention.

How to assess the gender?

The lack of a standardized measure of gender might be an obstacle for the integration of sex and gender in research and clinical practice. Several operational frameworks for integrating gender in clinical studies have been published.20,51–53

Based on the recently published guidelines in CV research, efforts should be made to prospectively collect gender-related variables as pertinent to their research hypothesis/questions and explore retrospectively available datasets using the GOING-FWD methodology.54

The gender working group of the Italian Society of Internal Medicine (SIMI), funded in 2019, have conceptualized based on the evidence available51,52 a list of variables that should be collected through questionnaire that capture gender domains in the clinical studies.53 Specifically, the gender core dataset consists of data regarding personality traits (gender identity), occupation, caregiver status, household responsibilities, condition of primary earner (gender roles), marital status, social support and discrimination (gender relations), and educational level, personal income and living area (institutionalized gender).

Possible tools to enhance inclusivity in cardiac rehabilitation

Several solutions might be available to fill the gap of lower rates in CR participation; however, first it would be beneficial to increase physicians’ awareness of the essential benefits related to this strategy of prevention.10,12 Moreover, it would help to invest substantial resources in the healthcare system to ensure high-quality and high-capacity rehabilitation centres.10,12 Improvements in counselling and social support may be necessary for major attendance to therapy.

Regarding specifical sex and gender-issues that limit participation to CR, a more tailored programmes based on women attitude and needing, that may lead to an increase in CR participation, and correct the modifiable barriers, through flexibility of timetable (with both morning and afternoon sessions) and strategy to manage stress might be helpful.49 Another important issue would be to promote the knowledge, between the physicians, of the four main domains (e.g. gender identity, gender roles, gender relations, and institutionalized gender) in line with the statement recently made by a panel of experts on an open-access CR education resources to support women in CV prevention through their participation in CR.55 As a benchmark of possible strategies, the million hearts initiative strive to prevent up to one million CV events through CR.56 Especially for women, with the aim of overcoming logistic problems, such as those related to transportation or the impossibility of leaving their houses, home-based programmes controlled by rehabilitation staff through telemedicine have been proposed and developed.57 The flexibility of this strategy allows physicians to follow the patient’s progresses in a partially or completely remote way, thereby facilitating their adherence through individual management regarding location and time. Likewise, smartphone-based CR used to monitor digitally the improvements in exercise capacity, symptomatology and changes in lifestyle is a promising tool to be considered, leading to a possible additional improvement in communication between patients and CR staff.57–59 A recent meta-analysis, collecting studies carried on patients with coronary heart disease, acute coronary syndrome who underwent cardiac revascularization procedures, or valvular replacement surgery, showed a favourable adherence to CR through digitalization instead of traditional programmes.60 The support by the healthcare system is another aspect that might help. In fact, the reduction of the costs related to rehabilitation positively encourages participation in the programme. Another specific aspect is the need for searching neuropsychiatric disorders (i.e. depression and anxiety) that may hardly limit the women participation to CR programmes; in addition, the inclusion in CR programmes of exercises to manage stress or anxiety (e.g. yoga techniques and mindfulness) demonstrated to increase the CR attendance.61 Another possible solution may be to identify CR strategies more pleasant for women; for instance, it has been described that exercise programmes based on dance classes and with a high level of aggregation are usually appreciated by women.49

Finally, an international panel of experts published a women focused CV rehabilitation clinical practice guideline, aimed to better engage women in CR programmes and to provide guidance on how to deliver women-focused CR programme. As a result, 15 final recommendations for women-focused CR have been proposed, relate to CR referral, setting, and delivery. Notably, of these recommendations, only two have a ‘high’ certainty of the evidence based on the grading of recommendations assessment, development, and evaluation criteria and 10 have been suggested with a strong level of recommendation,62 further supporting the need for sex and gender specific investigations.

Gaps in evidence

A profound gap in knowledge about the development of CR dynamics in the last decade still exists. For instance, in Italy, the more recent survey about the cardiac prevention and rehabilitation programmes dates to 2013.13 Here, it was highlighted that the total number of CR facilities amounted to 221 (1 for every 270 000 inhabitants), with 31.7% of programme response rate and at least 280 771 patients with an unmet need.12,23 Considering the broadening of the spectrum of CV disease for which CR has been now recommended in the most recent updates by the European Guidelines,10 the pool of potential patients has been extended, further widening the gap between supply and demand. Several issues are worth to be acknowledged regarding the difficulties to understand the gender related obstacles in ensuring gender equality and inclusivity in CV rehabilitation. Among sex-related differences, presentation of cardiac disease and comorbidities pose challenges specific to each sex. Women often exhibit atypical symptoms and are more likely to suffer from conditions like auto-immune diseases, osteoporosis and arthritis, which can complicate their participation in CR programmes.63–65 On the other hand, current society do not allow women to take care of their health properly. It is a matter of fact that women commonly face greater barriers due to caregiving responsibilities, reduced social support for physical activity, and different health beliefs. Women are often less aware of the benefits of CR and underestimate their heart disease risk.66,67 Socioeconomic factors further impact, considering that women are more likely to have lower incomes, less health insurance coverage, and greater difficulty accessing healthcare services.68 Higher prevalence of depression and anxiety among women can hinder their participation in CR.30 Addressing these obstacles require tailored interventions that consider both biological and socio-cultural dimensions to improve CR utilization and outcomes for women (see Table 3).

Table 3

Specific obstacles to perform research on barriers due to sex and gender in cardiovascular research

Obstacle typeSpecific obstaclesReference
Biological (sex-specific) obstacles
  • Atypical symptom presentation in women

  • Higher prevalence of comorbidities such as osteoporosis autoimmune diseases and arthritis in women

Ades et al.,56 Joseph et al.,64 Angum et al.,65 and Sanderson and Bittner66
Socio-cultural (gender-specific) obstacles
  • Greater caregiving responsibilities among women

  • Reduced social support for physical activity among women

  • Lower awareness of CR benefits and underestimation of heart disease risk among women

  • Lower incomes, less health insurance coverage, and greater difficulty accessing healthcare services among women

Daponte-Codina et al.67 and Daher et al.68
Obstacle typeSpecific obstaclesReference
Biological (sex-specific) obstacles
  • Atypical symptom presentation in women

  • Higher prevalence of comorbidities such as osteoporosis autoimmune diseases and arthritis in women

Ades et al.,56 Joseph et al.,64 Angum et al.,65 and Sanderson and Bittner66
Socio-cultural (gender-specific) obstacles
  • Greater caregiving responsibilities among women

  • Reduced social support for physical activity among women

  • Lower awareness of CR benefits and underestimation of heart disease risk among women

  • Lower incomes, less health insurance coverage, and greater difficulty accessing healthcare services among women

Daponte-Codina et al.67 and Daher et al.68
Table 3

Specific obstacles to perform research on barriers due to sex and gender in cardiovascular research

Obstacle typeSpecific obstaclesReference
Biological (sex-specific) obstacles
  • Atypical symptom presentation in women

  • Higher prevalence of comorbidities such as osteoporosis autoimmune diseases and arthritis in women

Ades et al.,56 Joseph et al.,64 Angum et al.,65 and Sanderson and Bittner66
Socio-cultural (gender-specific) obstacles
  • Greater caregiving responsibilities among women

  • Reduced social support for physical activity among women

  • Lower awareness of CR benefits and underestimation of heart disease risk among women

  • Lower incomes, less health insurance coverage, and greater difficulty accessing healthcare services among women

Daponte-Codina et al.67 and Daher et al.68
Obstacle typeSpecific obstaclesReference
Biological (sex-specific) obstacles
  • Atypical symptom presentation in women

  • Higher prevalence of comorbidities such as osteoporosis autoimmune diseases and arthritis in women

Ades et al.,56 Joseph et al.,64 Angum et al.,65 and Sanderson and Bittner66
Socio-cultural (gender-specific) obstacles
  • Greater caregiving responsibilities among women

  • Reduced social support for physical activity among women

  • Lower awareness of CR benefits and underestimation of heart disease risk among women

  • Lower incomes, less health insurance coverage, and greater difficulty accessing healthcare services among women

Daponte-Codina et al.67 and Daher et al.68

Finally, there are no specific analyses regarding the proper role of sex and gender and no definite strategies to increase women adherence to CR programme.

Conclusions

Despite its role as prevention tool to improve clinical outcomes of patients affected by CV diseases, to date CR is still underused, particularly by women. The identification of patients’ obstacles to attend CR related to sex and gender differences has a non-neglectable impact. In fact, every subject should be considered beyond the biological sex in agreement with the four gender domains, to craft tailored therapies.

Every patient identifies his/her own gender, while the society considers and interacts with him/her on basis of the sex. Furthermore, the institutionalized gender might represent the distribution of power between genders in the political, educational, religious, medical, cultural, and social institutions. All that should be considered in the management of the individual to improve clinical outcomes. According to CR, possible tools to optimize patients’ participation are represented by increased referral rate related to physicians’ awareness of the essential benefits of CR, strengthening in healthcare system facilities, patients’ information after hospital discharge, tailored rehabilitation programmes, and the use of telemedicine and telemonitoring to allow a stricter connection between CR staff and patient and to contrast socio-economic problems or familial and logistic obstacles. International scientific societies and ministerial governance should be involved in this process to reduce sex and gender inequality in CR attendance.

Lead author biography

graphic

Prof. Antonio Cittadini is full Professor of Medicine at the ‘Federico II’ University of Naples and Director of the Department of Internal Medicine and clinical complexity at the ‘Federico II’ University Hospital in Naples. He spent a research Fellowship in Cardiology at Harvard Medical School, Boston, MA (1993–1997) where he was also appointed as Instructor of Medicine. Author of more than 250 scientific articles (Hirsch Index 54, 10 104 citations) mainly devoted to secondary prevention in post-infarction and chronic HF patients. He is director of the centre for Gender Medicine Research ‘GENESIS’ at the ‘Federico II’ University of Naples.

Data availability

No new data were generated or analysed in support of this research.

Acknowledgements

Dr. Federica Giardino MD received research grant by the Cardiovascular Pathophysiology and Therapeutics (CardioPath) programme from the University of Naples Federico II, Italy.

Funding

None.

References

1

Bozkurt
 
B
,
Fonarow
 
GC
,
Goldberg
 
LR
,
Guglin
 
M
,
Josephson
 
RA
,
Forman
 
DE
,
Lin
 
G
,
Lindenfeld
 
J
,
O’Connor
 
C
,
Panjrath
 
G
,
Piña
 
IL
,
Shah
 
T
,
Sinha
 
SS
,
Wolfel
 
E
;
ACC’s Heart Failure and Transplant Section and Leadership Council
.
Cardiac rehabilitation for patients with heart failure: JACC expert panel
.
J Am Coll Cardiol
 
2021
;
77
:
1454
1469
.

2

Taylor
 
RS
,
Dalal
 
HM
,
McDonagh
 
STJ
.
The role of cardiac rehabilitation in improving cardiovascular outcomes
.
Nat Rev Cardiol
 
2022
;
19
:
180
194
.

3

Bäck
 
M
,
Hansen
 
TB
.
ESC cardiac rehabilitation and exercise training recommendations. Cardiac rehabilitation: rationale, indications and core components
.
2017
 https://www.escardio.org/Education/ESC-Prevention-of-CVD-Programme/Rehabilitation.

4

Knuuti
 
J
,
Wijns
 
W
,
Saraste
 
A
,
Capodanno
 
D
,
Barbato
 
E
,
Funck-Brentano
 
C
,
Prescott
 
E
,
Storey
 
RF
,
Deaton
 
C
,
Cuisset
 
T
,
Agewall
 
S
,
Dickstein
 
K
,
Edvardsen
 
T
,
Escaned
 
J
,
Gersh
 
BJ
,
Svitil
 
P
,
Gilard
 
M
,
Hasdai
 
D
,
Hatala
 
R
,
Mahfoud
 
F
,
Masip
 
J
,
Muneretto
 
C
,
Valgimigli
 
M
,
Achenbach
 
S
,
Bax
 
JJ
;
ESC Scientific Document Group
.
2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes.
 
Eur Heart J
 
2020
;
41
:
407
477
.
Erratum in: Eur Heart J. 2020 Nov 21; 41(44):4242

5

Virani
 
SS
,
Newby
 
LK
,
Arnold
 
SV
,
Bittner
 
V
,
Brewer
 
LC
,
Demeter
 
SH
,
Dixon
 
DL
,
Fearon
 
WF
,
Hess
 
B
,
Johnson
 
HM
,
Kazi
 
DS
,
Kolte
 
D
,
Kumbhani
 
DJ
,
LoFaso
 
J
,
Mahtta
 
D
,
Mark
 
DB
,
Minissian
 
M
,
Navar
 
AM
,
Patel
 
AR
,
Piano
 
MR
,
Rodriguez
 
F
,
Talbot
 
AW
,
Taqueti
 
VR
,
Thomas
 
RJ
,
van Diepen
 
S
,
Wiggins
 
B
,
Williams
 
MS
.
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology joint committee on clinical practice guidelines
.
Circulation
 
2023
;
148
:
e9
e119
.
Erratum in: Circulation. 2023 Sep 26; 148(13):e148. Erratum in: Circulation. 2023 Dec 5; 148(23):e186
.

6

Lawton
 
JS
,
Tamis-Holland
 
JE
,
Bangalore
 
S
,
Bates
 
ER
,
Beckie
 
TM
,
Bischoff
 
JM
,
Bittl
 
JA
,
Cohen
 
MG
,
DiMaio
 
JM
,
Don
 
CW
,
Fremes
 
SE
,
Gaudino
 
MF
,
Goldberger
 
ZD
,
Grant
 
MC
,
Jaswal
 
JB
,
Kurlansky
 
PA
,
Mehran
 
R
,
Metkus
 
TS
 Jr
,
Nnacheta
 
LC
,
Rao
 
SV
,
Sellke
 
FW
,
Sharma
 
G
,
Yong
 
CM
,
Zwischenberger
 
BA.
 
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines
.
Circulation
 
2022
;
145
:
e18
e114
.
Erratum in: Circulation. 2022 Mar 15; 145(11):e772

7

McMahon
 
SR
,
Ades
 
PA
,
Thompson
 
PD
.
The role of cardiac rehabilitation in patients with heart disease
.
Trends Cardiovasc Med
 
2017
;
27
:
420
425
.

8

McDonagh
 
TA
,
Metra
 
M
,
Adamo
 
M
,
Gardner
 
RS
,
Baumbach
 
A
,
Böhm
 
M
,
Burri
 
H
,
Butler
 
J
,
Čelutkienė
 
J
,
Chioncel
 
O
,
Cleland
 
JGF
,
Coats
 
AJS
,
Crespo-Leiro
 
MG
,
Farmakis
 
D
,
Gilard
 
M
,
Heymans
 
S
,
Hoes
 
AW
,
Jaarsma
 
T
,
Jankowska
 
EA
,
Lainscak
 
M
,
Lam
 
CSP
,
Lyon
 
AR
,
McMurray
 
JJV
,
Mebazaa
 
A
,
Mindham
 
R
,
Muneretto
 
C
,
Francesco Piepoli
 
M
,
Price
 
S
,
Rosano
 
GMC
,
Ruschitzka
 
F
,
Kathrine Skibelund
 
A
;
ESC Scientific Document Group
.
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
.
Eur Heart J
 
2021
;
42
:
3599
3726
.
Erratum in: Eur Heart J. 2021

9

Heidenreich
 
PA
,
Bozkurt
 
B
,
Aguilar
 
D
,
Allen
 
LA
,
Byun
 
JJ
,
Colvin
 
MM
,
Deswal
 
A
,
Drazner
 
MH
,
Dunlay
 
SM
,
Evers
 
LR
,
Fang
 
JC
,
Fedson
 
SE
,
Fonarow
 
GC
,
Hayek
 
SS
,
Hernandez
 
AF
,
Khazanie
 
P
,
Kittleson
 
MM
,
Lee
 
CS
,
Link
 
MS
,
Milano
 
CA
,
Nnacheta
 
LC
,
Sandhu
 
AT
,
Stevenson
 
LW
,
Vardeny
 
O
,
Vest
 
AR
,
Yancy
 
CW
.
2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines
.
Circulation
 
2022
;
145
:
e895
e1032
.
2022
.

10

Ambrosetti
 
M
,
Abreu
 
A
,
Corrà
 
U
,
Davos
 
CH
,
Hansen
 
D
,
Frederix
 
I
,
Iliou
 
MC
,
Pedretti
 
RFE
,
Schmid
 
JP
,
Vigorito
 
C
,
Voller
 
H
,
Wilhelm
 
M
,
Piepoli
 
MF
,
Bjarnason-Wehrens
 
B
,
Berger
 
T
,
Cohen-Solal
 
A
,
Cornelissen
 
V
,
Dendale
 
P
,
Doehner
 
W
,
Gaita
 
D
,
Gevaert
 
AB
,
Kemps
 
H
,
Kraenkel
 
N
,
Laukkanen
 
J
,
Mendes
 
M
,
Niebauer
 
J
,
Simonenko
 
M
,
Zwisler
 
AO
.
Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology
.
Eur J Prev Cardiol
 
2021
;
28
:
460
495
.

11

Ritchey
 
MD
,
Maresh
 
S
,
McNeely
 
J
,
Shaffer
 
T
,
Jackson
 
SL
,
Keteyian
 
SJ
,
Brawner
 
CA
,
Whooley
 
MA
,
Chang
 
T
,
Stolp
 
H
,
Schieb
 
L
,
Wright
 
J
.
Tracking cardiac rehabilitation participation and completion among medicare beneficiaries to inform the efforts of a national initiative
.
Circ Cardiovasc Qual Outcomes
 
2020
;
13
:
e005902
.

12

Pedretti
 
RFE
,
Fattirolli
 
F
,
Griffo
 
R
,
Ambrosetti
 
M
,
Angelino
 
E
,
Brazzo
 
S
,
Corrà
 
U
,
Dasseni
 
N
,
Faggiano
 
P
,
Favretto
 
G
,
Febo
 
O
,
Ferrari
 
M
,
Giallauria
 
F
,
Greco
 
C
,
Iannucci
 
M
,
La Rovere
 
MT
,
Mallardo
 
M
,
Mazza
 
A
,
Piepoli
 
M
,
Riccio
 
C
,
Scalvini
 
S
,
Tavazzi
 
L
,
Temporelli
 
PL
,
Mureddu
 
GF
.
Cardiac prevention and rehabilitation “3.0”: from acute to chronic phase. Position paper of the ltalian association for cardiovascular prevention and rehabilitation (GICR-IACPR)
.
Monaldi Arch Chest Dis
 
2018
;
88
:
1004
.

13

Griffo
 
R
,
Tramarin
 
R
,
Volterrani
 
M
,
Ambrosetti
 
M
,
Caiazza
 
F
,
Chimini
 
C
,
Favretto
 
G
,
Febo
 
O
,
Gabriele
 
M
,
Pusineri
 
E
,
Greco
 
C
,
Proto
 
C
;
Società Italiana Cardiologia Ospedalita Accreditata
.
Italian survey on cardiac rehabilitation (ISYDE.13-directory): report su strutture, organizzazione e programmi di cardiologia riabilitativa in Italia
.
G Ital Cardiol
 
2016
;
17
:
217
224
.

14

Thomas
 
RJ
.
Cardiac rehabilitation—challenges, advances, and the road ahead
.
N Engl J Med
 
2024
;
390
:
830
841
.

15

Li
 
S
,
Fonarow
 
GC
,
Mukamal
 
K
,
Xu
 
H
,
Matsouaka
 
RA
,
Devore
 
AD
,
Bhatt
 
DL
.
Sex and racial disparities in cardiac rehabilitation referral at hospital discharge and gaps in long-term mortality
.
J Am Heart Assoc
 
2018
;
7
:
e008088
.

16

Pandey
 
A
,
Keshvani
 
N
,
Zhong
 
L
,
Mentz
 
RJ
,
Piña
 
IL
,
DeVore
 
AD
,
Yancy
 
C
,
Kitzman
 
DW
,
Fonarow
 
GC
.
Temporal trends and factors associated with cardiac rehabilitation participation among medicare beneficiaries with heart failure
.
JACC Heart Fail
 
2021
;
9
:
471
481
.

17

Marra
 
AM
,
Salzano
 
A
,
Arcopinto
 
M
,
Piccioli
 
L
,
Raparelli
 
V
.
The impact of gender in cardiovascular medicine: lessons from the gender/sex-issue in heart failure
.
Monaldi Arch Chest Dis
 
2018
;
88
:
988
.

18

Johnson
 
JL
,
Greaves
 
L
,
Repta
 
R
.
Better science with sex and gender: facilitating the use of a sex and gender-based analysis in health research
.
Int J Equity Health
 
2009
;
8
:
14
.

19

Arcopinto
 
M
,
Valente
 
V
,
Giardino
 
F
,
Marra
 
AM
,
Cittadini
 
A
.
What have we learned so far from the sex/gender issue in heart failure? An overview of current evidence
.
Intern Emerg Med
 
2022
;
17
:
1589
1598
.

20

Usselman
 
CW
,
Lindsey
 
ML
,
Robinson
 
AT
,
Habecker
 
BA
,
Taylor
 
CE
,
Merryman
 
WD
,
Kimmerly
 
D
,
Bender
 
JR
,
Regensteiner
 
JG
,
Moreau
 
KL
,
Pilote
 
L
,
Wenner
 
MM
,
O’Brien
 
M
,
Yarovinsky
 
TO
,
Stachenfeld
 
NS
,
Charkoudian
 
N
,
Denfeld
 
QE
,
Moreira-Bouchard
 
JD
,
Pyle
 
WG
,
DeLeon-Pennell
 
KY
.
Guidelines on the use of sex and gender in cardiovascular research
.
Am J Physiol Heart Circ Physiol
 
2024
;
326
:
H238
H255
.

21

Deb
 
B
,
Porter
 
K
,
van Cleeff
 
A
,
Reardon
 
LC
,
Cook
 
S
.
Emphasizing sexual orientation and gender identity data capture for improved cardiovascular care of the LGBTQ+ population
.
JAMA Cardiol
 
2024
;
9
:
295
.

22

Smith
 
JR
,
Thomas
 
RJ
,
Bonikowske
 
AR
,
Hammer
 
SM
,
Olson
 
TP.
 
Sex differences in cardiac rehabilitation outcomes
.
Circ Res
 
2022
;
130
:
552
565
.
Erratum in: Circ Res. 2022 Mar 18; 130(6):e22

23

Abreu
 
A
,
Pesah
 
E
,
Supervia
 
M
,
Turk-Adawi
 
K
,
Bjarnason-Wehrens
 
B
,
Lopez-Jimenez
 
F
,
Ambrosetti
 
M
,
Andersen
 
K
,
Giga
 
V
,
Vulic
 
D
,
Vataman
 
E
,
Gaita
 
D
,
Cliff
 
J
,
Kouidi
 
E
,
Yagci
 
I
,
Simon
 
A
,
Hautala
 
A
,
Tamuleviciute-Prasciene
 
E
,
Kemps
 
H
,
Eysymontt
 
Z
,
Farsky
 
S
,
Hayward
 
J
,
Prescott
 
E
,
Dawkes
 
S
,
Pavy
 
B
,
Kiessling
 
A
,
Sovova
 
E
,
Grace
 
SL
.
Cardiac rehabilitation availability and delivery in Europe: how does it differ by region and compare with other high-income countries? Endorsed by the European Association of Preventive Cardiology
.
Eur J Prev Cardiol
 
2019
;
26
:
1131
1146
.

24

Canto
 
JG
,
Rogers
 
WJ
,
Goldberg
 
RJ
,
Peterson
 
ED
,
Wenger
 
NK
,
Vaccarino
 
V
,
Kiefe
 
CI
,
Frederick
 
PD
,
Sopko
 
G
,
Zheng
 
ZJ
;
NRMI Investigators
.
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality
.
JAMA
 
2012
;
307
:
813
822
.

25

Samayoa
 
L
,
Grace
 
SL
,
Gravely
 
S
,
Scott
 
LB
,
Marzolini
 
S
,
Colella
 
TJ
.
Sex differences in cardiac rehabilitation enrollment: a meta-analysis
.
Can J Cardiol
 
2014
;
30
:
793
800
.

26

Colella
 
TJ
,
Gravely
 
S
,
Marzolini
 
S
,
Grace
 
SL
,
Francis
 
JA
,
Oh
 
P
,
Scott
 
LB
.
Sex bias in referral of women to outpatient cardiac rehabilitation? A meta-analysis
.
Eur J Prev Cardiol
 
2015
;
22
:
423
441
.

27

Colbert
 
JD
,
Martin
 
BJ
,
Haykowsky
 
MJ
,
Hauer
 
TL
,
Austford
 
LD
,
Arena
 
RA
,
Knudtson
 
ML
,
Meldrum
 
DA
,
Aggarwal
 
SG
,
Stone
 
JA
.
Cardiac rehabilitation referral, attendance and mortality in women
.
Eur J Prev Cardiol
 
2015
;
22
:
979
986
.

28

Hussain Jafri
 
SH
,
Ngamdu
 
KS
,
Price
 
D
,
Baloch
 
ZQ
,
Cohn
 
J
,
Wilcox
 
M
,
Freeman
 
AM
,
Ornish
 
D
,
Wu
 
WC
.
Intensive cardiac rehabilitation attenuates the gender gap in cardiac rehabilitation participation
.
Curr Probl Cardiol
 
2023
;
48
:
101668
.

29

Oosenbrug
 
E
,
Marinho
 
RP
,
Zhang
 
J
,
Marzolini
 
S
,
Colella
 
TJ
,
Pakosh
 
M
,
Grace
 
SL
.
Sex differences in cardiac rehabilitation adherence: a meta-analysis
.
Can J Cardiol
 
2016
;
32
:
1316
1324
.

30

Ghisi
 
GLM
,
Kim
 
WS
,
Cha
 
S
,
Aljehani
 
R
,
Cruz
 
MMA
,
Vanderlei
 
LCM
,
Pepera
 
G
,
Liu
 
X
,
Xu
 
Z
,
Maskhulia
 
L
,
Venturini
 
E
,
Chuang
 
HJ
,
Pereira
 
DG
,
Trevizan
 
PF
,
Kouidi
 
E
,
Batalik
 
L
,
Ghanbari Firoozabadi
 
M
,
Burazor
 
I
,
Jiandani
 
MP
,
Zhang
 
L
,
Tourkmani
 
N
,
Grace
 
SL
.
Women's cardiac rehabilitation barriers: results of the international council of cardiovascular prevention and rehabilitation’s first global assessment
.
Can J Cardiol
 
2023
;
39
:
S375
S383
.

31

Supervia
 
M
,
Medina-Inojosa
 
J
,
Jarreta
 
BM
,
Lopez-Jimenez
 
F
,
Douglas
 
KV
,
Terzic
 
CM
,
Thomas
 
RJ
.
Cardiac rehabilitation completion study: barriers and potential solutions
.
J Cardiopulm Rehabil Prev
 
2022
;
42
:
375
377
.

32

D'Agostino
 
A
,
Guindani
 
P
,
Scaglione
 
G
,
Vincenzo
 
AD
,
Tamascelli
 
S
,
Spaggiari
 
R
,
Salzano
 
A
,
D'Amuri
 
A
,
Marra
 
AM
,
Pilote
 
L
,
Raparelli
 
V.
 
Sex- and gender-related aspects in pulmonary hypertension
.
Heart Fail Clin
 
2023
;
19
:
11
24
.

33

Streed
 
CG
 Jr,
Beach
 
LB
,
Caceres
 
BA
,
Dowshen
 
NL
,
Moreau
 
KL
,
Mukherjee
 
M
,
Poteat
 
T
,
Radix
 
A
,
Reisner
 
SL
,
Singh
 
V
;
American Heart Association Council on Peripheral Vascular Disease
;
Council on Arteriosclerosis, Thrombosis and Vascular Biology
;
Council on Cardiovascular and Stroke Nursing
;
Council on Cardiovascular Radiology and Intervention
;
Council on Hypertension
;
Stroke Council
.
Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association
.
Circulation
 
2021
;
144
:
e136
e148
.
Erratum in: Circulation. 2021; 144(6):e150

34

James
 
SE
,
Herman
 
JL
,
Rankin
 
S
,
Keisling
 
M
,
Mottet
 
L
,
Anafi
 
M
.
The report of the 2015U.S. Transgender survey
.
Washington, DC
:
National Center for Transgender Equality
;
2016
.

35

Alzahrani
 
T
,
Nguyen
 
T
,
Ryan
 
A
,
Dwairy
 
A
,
McCaffrey
 
J
,
Yunus
 
R
,
Forgione
 
J
,
Krepp
 
J
,
Nagy
 
C
,
Mazhari
 
R
,
Reiner
 
J
.
Cardiovascular disease risk factors and myocardial infarction in the transgender population
.
Circ Cardiovasc Qual Outcomes
 
2019
;
12
:
e005597
.

36

Connelly
 
PJ
,
Marie Freel
 
E
,
Perry
 
C
,
Ewan
 
J
,
Touyz
 
RM
,
Currie
 
G
,
Delles
 
C
.
Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults
.
Hypertension
 
2019
;
74
:
1266
1274
.
Erratum in: Hypertension. 2020 Apr; 75(4):e10
.

37

Angus
 
JE
,
King-Shier
 
KM
,
Spaling
 
MA
,
Duncan
 
AS
,
Jaglal
 
SB
,
Stone
 
JA
,
Clark
 
AM
.
A secondary meta-synthesis of qualitative studies of gender and access to cardiac rehabilitation
.
J Adv Nurs
 
2015
;
71
:
1758
1773
.

38

Traywick
 
LS
,
Schoenberg
 
NE
.
Determinants of exercise among older female heart attack survivors
.
J Appl Gerontol
 
2008
;
27
:
52
77
.

39

Molloy
 
GJ
,
Hamer
 
M
,
Randall
 
G
,
Chida
 
Y
.
Marital status and cardiac rehabilitation attendance: a meta-analysis
.
Eur J Cardiovasc Prev Rehabil
 
2008
;
15
:
557
561
.

40

Doll
 
JA
,
Hellkamp
 
A
,
Ho
 
PM
,
Kontos
 
MC
,
Whooley
 
MA
,
Peterson
 
ED
,
Wang
 
TY
.
Participation in cardiac rehabilitation programs among older patients after acute myocardial infarction
.
JAMA Intern Med
 
2015
;
175
:
1700
1702
.

41

Ruano-Ravina
 
A
,
Pena-Gil
 
C
,
Abu-Assi
 
E
,
Raposeiras
 
S
,
van ‘t Hof
 
A
,
Meindersma
 
E
,
Bossano Prescott
 
EI
,
González-Juanatey
 
JR
.
Participation and adherence to cardiac rehabilitation programs. A systematic review
.
Int J Cardiol
 
2016
;
223
:
436
443
.

42

van Engen-Verheul
 
M
,
de Vries
 
H
,
Kemps
 
H
,
Kraaijenhagen
 
R
,
de Keizer
 
N
,
Peek
 
N
.
Cardiac rehabilitation uptake and its determinants in The Netherlands
.
Eur J Prev Cardiol
 
2013
;
20
:
349
356
.

43

Shanmugasegaram
 
S
,
Gagliese
 
L
,
Oh
 
P
,
Stewart
 
DE
,
Brister
 
SJ
,
Chan
 
V
,
Grace
 
SL
.
Psychometric validation of the cardiac rehabilitation barriers scale
.
Clin Rehabil
 
2012
;
26
:
152
164
.

44

Grace
 
SL
,
Gravely-Witte
 
S
,
Kayaniyil
 
S
,
Brual
 
J
,
Suskin
 
N
,
Stewart
 
DE
.
A multisite examination of sex differences in cardiac rehabilitation barriers by participation status
.
J Womens Health (Larchmt)
 
2009
;
18
:
209
216
.

45

Firoozabadi
 
MG
,
Mirzaei
 
M
,
Grace
 
SL
,
Vafaeinasab
 
M
,
Dehghani-Tafti
 
M
,
Sadeghi
 
A
,
Asadi
 
Z
,
Basirinezhad
 
MH
.
Sex differences in cardiac rehabilitation barriers among non-enrollees in the context of lower gender equality: a cross-sectional study
.
BMC Cardiovasc Disord
 
2023
;
23
:
329
.

46

Supervía
 
M
,
Medina-Inojosa
 
JR
,
Yeung
 
C
,
Lopez-Jimenez
 
F
,
Squires
 
RW
,
Pérez-Terzic
 
CM
,
Brewer
 
LC
,
Leth
 
SE
,
Thomas
 
RJ
.
Cardiac rehabilitation for women: a systematic review of barriers and solutions
.
Mayo Clin Proc
 
2017
; doi:10.1016/j.mayocp.2017.01.002

47

Khadanga
 
S
,
Gaalema
 
DE
,
Savage
 
P
,
Ades
 
PA
.
Underutilization of cardiac rehabilitation in women: BARRIERS AND SOLUTIONS
.
J Cardiopulm Rehabil Prev
 
2021
;
41
:
207
213
.

48

Resurrección
 
DM
,
Motrico
 
E
,
Rigabert
 
A
,
Rubio-Valera
 
M
,
Conejo-Cerón
 
S
,
Pastor
 
L
,
Moreno-Peral
 
P
.
Barriers for nonparticipation and dropout of women in cardiac rehabilitation programs: a systematic review
.
J Womens Health (Larchmt)
 
2017
;
26
:
849
859
.

49

Galati
 
A
,
Piccoli
 
M
,
Tourkmani
 
N
,
Sgorbini
 
L
,
Rossetti
 
A
,
Cugusi
 
L
,
Bellotto
 
F
,
Mercuro
 
G
,
Abreu
 
A
,
D'Ascenzi
 
F
;
Working Group on Cardiac Rehabilitation of the Italian Society of Cardiology
.
Cardiac rehabilitation in women: state of the art and strategies to overcome the current barriers
.
J Cardiovasc Med (Hagerstown)
 
2018
;
19
:
689
697
.

50

Clark
 
AM
,
King-Shier
 
KM
,
Duncan
 
A
,
Spaling
 
M
,
Stone
 
JA
,
Jaglal
 
S
,
Angus
 
J
.
Factors influencing referral to cardiac rehabilitation and secondary prevention programs: a systematic review
.
Eur J Prev Cardiol
 
2013
;
20
:
692
700
.

51

Pelletier
 
R
,
Ditto
 
B
,
Pilote
 
L
.
A composite measure of gender and its association with risk factors in patients with premature acute coronary syndrome
.
Psychosom Med
 
2015
;
77
:
517
526
.

52

Nielsen
 
MW
,
Stefanick
 
ML
,
Peragine
 
D
,
Neilands
 
TB
,
Ioannidis
 
JPA
,
Pilote
 
L
,
Prochaska
 
JJ
,
Cullen
 
MR
,
Einstein
 
G
,
Klinge
 
I
,
LeBlanc
 
H
,
Paik
 
HY
,
Schiebinger
 
L
.
Gender-related variables for health research
.
Biol Sex Differ
 
2021
;
12
:
23
.

53

Raparelli
 
V
,
Santilli
 
F
,
Marra
 
AM
,
Romiti
 
GF
,
Succurro
 
E
,
Licata
 
A
,
Buzzetti
 
E
,
Piano
 
S
,
Masala
 
M
,
Suppressa
 
P
,
Becattini
 
C
,
Muiesan
 
ML
,
Russo
 
G
,
Cogliati
 
C
,
Proietti
 
M
,
Basili
 
S
;
Italian Society of Internal Medicine (SIMI)
.
The SIMI gender ‘5 Ws’ rule for the integration of sex and gender-related variables in clinical studies towards internal medicine equitable research
.
Intern Emerg Med
 
2022
;
17
:
1969
1976
.

54

Raparelli
 
V
,
Norris
 
CM
,
Bender
 
U
,
Herrero
 
MT
,
Kautzky-Willer
 
A
,
Kublickiene
 
K
,
El Emam
 
K
,
Pilote
 
L
;
GOING-FWD Collaborators
.
Identification and inclusion of gender factors in retrospective cohort studies: the GOING-FWD framework
.
BMJ Glob Health
 
2021
;
6
:
e005413
.

55

Ghisi
 
GLM
,
Hebert
 
AA
,
Oh
 
P
,
Colella
 
T
,
Aultman
 
C
,
Carvalho
 
C
,
Nijhawan
 
R
,
Ross
 
MK
,
Grace
 
SL
.
Evidence-informed development of women-focused cardiac rehabilitation education
.
Heart Lung
 
2023
;
64
:
14
23
.

56

Ades
 
PA
,
Keteyian
 
SJ
,
Wright
 
JS
,
Hamm
 
LF
,
Lui
 
K
,
Newlin
 
K
,
Shepard
 
DS
,
Thomas
 
RJ
.
Increasing cardiac rehabilitation participation from 20% to 70%: a road map from the million hearts cardiac rehabilitation collaborative
.
Mayo Clin Proc
 
2017
;
92
:
234
242
.

57

Sawan
 
MA
,
Calhoun
 
AE
,
Fatade
 
YA
,
Wenger
 
NK
.
Cardiac rehabilitation in women, challenges and opportunities
.
Prog Cardiovasc Dis
 
2022
;
70
:
111
118
.

58

Hatch
 
V
,
Davies
 
WR
.
Digitally enabled cardiac rehabilitation following coronary revascularization: results from a single centre feasibility study
.
Eur Heart J Suppl
 
2022
;
24
:
H25
H31
.

59

Salzano
 
A
,
D'Assante
 
R
,
Stagnaro
 
FM
,
Valente
 
V
,
Crisci
 
G
,
Giardino
 
F
,
Arcopinto
 
M
,
Bossone
 
E
,
Marra
 
AM
,
Cittadini
 
A.
 
Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre
.
Eur J Heart Fail
 
2020
;
22
:
1048
1050
.

60

Popovici
 
M
,
Ursoniu
 
S
,
Feier
 
H
,
Mocan
 
M
,
Tomulescu
 
OMG
,
Kundnani
 
NR
,
Valcovici
 
M
,
Dragan
 
SR
.
Benefits of using smartphones and other digital methods in achieving better cardiac rehabilitation goals: a systematic review and meta-analysis
.
Med Sci Monit
 
2023
;
29
:
e939132
.

61

Mosca
 
L
,
Barrett-Connor
 
E
,
Wenger
 
NK
.
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes
.
Circulation
 
2011
;
124
:
2145
2154
.

62

Ghisi
 
GLM
,
Kin
 
SMR
,
Price
 
J
,
Beckie
 
TM
,
Mamataz
 
T
,
Naheed
 
A
,
Grace
 
SL
.
Women-focused cardiovascular rehabilitation: an international council of cardiovascular prevention and rehabilitation clinical practice guideline
.
Can J Cardiol
 
2022
;
38
:
1786
1798
.

63

Ades
 
PA
,
Waldmann
 
ML
,
McCann
 
WJ
,
Weaver
 
SO
.
Predictors of cardiac rehabilitation participation in older coronary patients
.
Arch Intern Med
 
1992
;
152
:
1033
1035
.

64

Joseph
 
NM
,
Ramamoorthy
 
L
,
Satheesh
 
S
.
Atypical manifestations of women presenting with myocardial infarction at tertiary health care center: an analytical study
.
J Midlife Health
 
2021
;
12
:
219
224
.

65

Angum
 
F
,
Khan
 
T
,
Kaler
 
J
,
Siddiqui
 
L
,
Hussain
 
A
.
The prevalence of autoimmune disorders in women: a narrative review
.
Cureus
 
2020
;
12
:
e8094
.

66

Sanderson
 
BK
,
Bittner
 
V
.
Women in cardiac rehabilitation: outcomes and identifying risk for dropout
.
Am Heart J
 
2005
;
150
:
1052
1058
.

67

Daponte-Codina
 
A
,
Knox
 
EC
,
Mateo-Rodriguez
 
I
,
Seims
 
A
,
Regitz-Zagrosek
 
V
,
Maas
 
AHEM
,
White
 
A
,
Barnhoorn
 
F
,
Rosell-Ortiz
 
F
.
Gender and social inequalities in awareness of coronary artery disease in European countries
.
Int J Environ Res Public Health
 
2022
;
19
:
1388
.

68

Daher
 
M
,
Al Rifai
 
M
,
Kherallah
 
RY
,
Rodriguez
 
F
,
Mahtta
 
D
,
Michos
 
ED
,
Khan
 
SU
,
Petersen
 
LA
,
Virani
 
SS
.
Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: the CDC behavioral risk factor surveillance system (BRFSS) survey
.
Prev Med
 
2021
;
153
:
106779
.

Author notes

Alberto M Marra and Federica Giardino contributed equally.

Conflict of interest: none declared.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected].
Handling Editor: Magnus Bäck
Magnus Bäck
Handling Editor
Search for other works by this author on:

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.